Controlling culture dynamics for the expansion of hematopoietic stem cells

Journal of Hematotherapy and Stem Cell Research

Volumn 10, Issue 4, 2001, Pages 481-492

  Madlambayan, G J ^a,b   Rogers, I ^d   Casper, R F ^d   Zandstra, P W ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b Departments of Chemical Engineering and Applied Chemistry   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOPROCESS; CELL CULTURE; CELL GROWTH; FEEDBACK SYSTEM; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; PRIORITY JOURNAL;

EID: 0034889611     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/15258160152509091     Document Type: Article

References (144)

1. Placental and/or umbilical cord blood: An alternative source of hematopoietic stem cells for transplantation
2. Allogeneic sibling umbilical-cordblood transplantation in children with malignant and nonmalignant disease
3. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease
4. The frequency and proliferative potential of megakaryocytic colony-forming cells (Meg-CFC) in cord blood, cytokine-mobilized peripheral blood and bone marrow, and their correlation with total CFC numbers: Implications for the quantitation of Meg-CFC to predict platelet engraftment following cord blood transplantation
5. Outcome of cord-blood transplantation from related and unrelated donors
6. Mixed chimerism and transplantation tolerance
7. From marrow to brain: Expression of neuronal phenotypes in adult mice
8. Dystrophin expression in the mdx mouse restored by stem cell transplantation
9. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo
10. Can stem cells cross lineage boundaries?
11. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains
12. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell
13. Human cord blood progenitors: Kinetics, regulation and their use for hemopoietic reconstitution
14. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling
15. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells
16. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay
17. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults
18. Transplantation of umbilical cord blood after myeloablative therapy: Analysis of engraftment
19. + cell recovery
20. Hemopoietic stem cell differentiation
21. Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice
22. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell
23. Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy
24. Distinct classes of human stem cells that differ in proliferative and self-renewal potential
25. Life span of multipotential hematopoietic stem cells in vivo
26. Developmental potential and dynamic behavior of hematopoietic stem cells
27. Hematopoietic stem cells expand during serial transplantation in vivo without apparent exhaustion
28. CD34: Structure, biology, and clinical utility
29. - progenitor cells
30. Isolation of a candidate human hematopoietic stem-cell population
31. Expression of Thy-1 on human hematopoietic progenitor cells
32. + human cord blood cells
33. + cells from human umbilical cord blood
34. + HLA-DR-bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis
35. CD34: To select or not to select? That is the question
36. The genetic program of hematopoietic stem cells
37. Resolution of pluripotential intermediates in murine hematopoietic differentiation by global complementary DNA amplification from single cells: Confirmation of assignments by expression profiling of cytokine receptor transcripts
38. Cytokine manipulation of primitive human hematopoietic cell self-renewal
39. A comparison of long-term repopulating hematopoietic stem cells in fetal liver and adult bone marrow from the mouse
40. Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-2, and granulocyte colony-stimulating factor
41. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro
42. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers
43. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice
44. Engraftment of immune-deficient mice with human hematopoietic stem cells
45. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice
46. Normal and leukemic human stem cells assayed in SCID mice
47. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice
48. Engraftment and development of human CD34(+)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice
49. + peripheral blood progenitor cells
50. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy
51. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells
52. VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin
53. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population
54. The biology of hematopoietic stem cells
55. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice
56. Hematopoietic stem cells: Inferences from in vivo assays
57. High frequency of long-term culture-initiating cells retain in vivo repopulation and self-renewal capacity
58. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice
59. A secreted and LIF-mediated stromal cell-derived activity that promotes ex vivo expansion of human hematopoietic stem cells
60. Expansion of human cord blood CD34(+) CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: Dissociation of SRC phenotype and function
61. A newly discovered class of human hematopoietic cells with SCID-repopulating activity
62. Engraftment and multilineage expression of human bone marrow CD34-cells in vivo
63. Kinetics of engraftment of CD34(-) and CD34(+) cells from mobilized blood differs from that of CD34(-) and CD34(+) cells from bone marrow
64. Reciprocal expression of CD38 and CD34 by adult murine hematopoietic stem cells
65. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor
66. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: Evidence for the amplification and self-renewal of repopulating stem cells
67. Gp130-signaling synergizes with FL and TPO for the long-term expansion of cord blood progenitors
68. Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin
69. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment
70. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells
71. The relative quiescence of hematopoietic stem cells in nonhuman primates
72. Cellular determinants affecting the rate of cytokine depletion in cultures of human hematopoietic cells
73. -) human hematopoietic cells: Novel responses to Flt3-ligand and thrombopoietin
74. Ontogeny-associated changes in the cytokine responses of primitive human haemopoietic cells
75. Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells
76. Stem cell factor and hematopoiesis
77. Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells
78. Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand
79. c-kit ligand and Flt3 ligand: Stem/progenitor cell factors with overlapping yet distinct activities
80. Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand
81. - cells and maintains progenitor cells in vitro
82. ++ + human umbilical cord blood myeloid progenitors in serum-depleted culture medium
83. FLT3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction
84. FLT3 ligand inhibits apoptosis and promotes survival of myeloid leukemia cell lines
85. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3
86. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+CD38-) human bone marrow progenitor cells: Distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha
87. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood
88. The role of c-Mp1 ligands in the expansion of cord blood hematopoietic progenitors
89. Thrombopoietin is synergistic with other cytokines for expansion of cord blood progenitor cells
90. Thrombopoietin, steel factor and the ligand for flt3/flk2 interact to stimulate the proliferation of human hematopoietic progenitors in culture
91. - cells with preserved ability to engraft SCID-hu bone
92. Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells
93. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells
94. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch 1 signaling
95. + cells purified from cord blood and fetal liver
96. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression
97. MCP-1, not MIP-1 alpha, is the endogenous chemokine that cooperates with TGF-beta to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures
98. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner
99. Human CD34(+) bone marrow cells regulate stromal production of interleukin-6 and granulocyte colony-stimulating factor and increase the colony-stimulating activity of stroma
100. Dynamic changes in mouse hematopoietic stem cell numbers during aging
101. Math1 is essential for genesis of cerebellar granule neurons
102. The EGF receptor defines domains of cell cycle progression and survival to regulate cell number in the developing Drosophila eye
103. Cytokine signaling for proliferation, survival, and death in hematopoietic cells
104. MN20, a D2 cyclin, is transiently expressed in selected neural populations during embryogenesis
105. Cell cycle length affects gene expression and pattern formation in limbs
106. Cyclin D1 provides a link between development and oncogenesis in the retina and breast
107. Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation
108. + Progenitor-Stromal Cell Coculture Systems: Effects of progenitor isolation method and cell-cell contact
109. High proliferative potential-quiescent cells: A working model to study primitive quiescent hematopoietic cells
110. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-beta
111. TNF-alpha bidirectionally modulates the viability of primitive murine hematopoietic progenitor cells in vitro
112. Modulation of bcl-2 and p27 in human primitive proliferating hematopoietic progenitors by autocrine TGF-beta1 is a cell cycle-independent effect and influences their hematopoietic potential
113. Transforming growth factor beta1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells
114. Transforming growth factor beta directly regulates primitive murine hematopoietic cell proliferation
115. Transforming growth factor-beta: Pleiotropic role in the regulation of hematopoiesis
116. TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation
117. Release from quiescence of primitive human hematopoietic stem/progenitor cells by blocking their cell-surface TGF-beta type II receptor in a short-term in vitro assay
118. Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells
119. Accelerated cell-cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-beta
120. Accelerated cell-cycling of hematopoietic progenitor cells by growth factors
121. Transforming growth factor beta 1 inhibits expression of the gene products for steel factor and its receptor (c-kit)
122. Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors
123. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta
124. Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors to potently and directly inhibited by transforming growth factor-beta and tumor necrosis factor-alpha
125. The Fas death factor
126. Environmental requirements of hematopoietic progenitor cells in ex vivo expansion systems
127. Interleukin 3 or interleukin 1 abrogates the reonstituting ability of hematopoietic stem cells
128. Negative influence of il3 on the expansion of human cord blood in vivo long-term repopulating stem cells
129. Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1
130. Cytokines in context
131. Quantitative long-term culture-initiating cell assays require accessory cell depletion that can be achieved by CD34-enrichment or 5-fluorouracil exposure
132. + cell selection and perfusion on ex vivo expansion of peripheral blood mononuclear cells
133. Functional heterogeneity of the hematopoietic microenvironment: Rare stromal elements maintain long-term repopulating stem cells
134. - cells
135. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice
136. Direct contact with stroma inhibits proliferation of human long-term culture initiating cells
137. Cell identification and isolation on the basis of cytokine secretion: A novel tool for investigating immune responses
138. Gel microdroplets and flow cytometry: Rapid determination of antibody secretion by individual cells within a cell population
139. Differentiation stage-specific regulation of primitive human hematopoietic progenitor cycling by exogenous and endogenous inhibitors in an in vivo model
140. Selective expansion of cord blood Lin-hematopoietic stem cells
141. Expansion and differentiation of human hematopoietic cells from static cultures through small-scale bioreactors
142. Expansion of hematopoietic progenitor cell populations in stirred suspension bioreactors of normal human bone marrow cells
143. Hematopoietic transplant potential of unrelated cord blood: Critical issues
144. Characterization of hematopoietic cell expansion, oxygen uptake, and glycolysis in a controlled, stirred-tank bioreactor system